227 related articles for article (PubMed ID: 30854961)
1. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
Bhatia R; Rawal RK
Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
G AC; Gondru R; Li Y; Banothu J
Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
[TBL] [Abstract][Full Text] [Related]
6. Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents.
Shaik BB; Katari NK; Seboletswe P; Gundla R; Kushwaha ND; Kumar V; Singh P; Karpoormath R; Bala MD
Anticancer Agents Med Chem; 2023; 23(2):142-163. PubMed ID: 35440315
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
8. Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review.
Fotopoulos I; Hadjipavlou-Litina D
Med Chem; 2020; 16(3):272-306. PubMed ID: 31038071
[TBL] [Abstract][Full Text] [Related]
9. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments of Coumarin-based Hybrids in Drug Discovery.
Xia D; Liu H; Cheng X; Maraswami M; Chen Y; Lv X
Curr Top Med Chem; 2022 Mar; 22(4):269-283. PubMed ID: 34986774
[TBL] [Abstract][Full Text] [Related]
11. A review of coumarin derivatives in pharmacotherapy of breast cancer.
Musa MA; Cooperwood JS; Khan MO
Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
[TBL] [Abstract][Full Text] [Related]
12. Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of Angiogenesis.
Cui N; Lin DD; Shen Y; Shi JG; Wang B; Zhao MZ; Zheng L; Chen H; Shi JH
Anticancer Agents Med Chem; 2019; 19(10):1253-1261. PubMed ID: 30947677
[TBL] [Abstract][Full Text] [Related]
13. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
Song F; Huo X; Guo Z
Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
[TBL] [Abstract][Full Text] [Related]
14. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
15. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
16. Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases.
Ballazhi L; Popovski E; Jashari A; Imeri F; Ibrahimi I; Mikhova B; Mladenovska K
Acta Pharm; 2015 Mar; 65(1):53-63. PubMed ID: 25781704
[TBL] [Abstract][Full Text] [Related]
17. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.
Singh H; Singh JV; Bhagat K; Gulati HK; Sanduja M; Kumar N; Kinarivala N; Sharma S
Bioorg Med Chem; 2019 Aug; 27(16):3477-3510. PubMed ID: 31255497
[TBL] [Abstract][Full Text] [Related]
18. Coumarins: old compounds with novel promising therapeutic perspectives.
Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.
Goud NS; Kumar P; Bharath RD
Mini Rev Med Chem; 2020; 20(17):1754-1766. PubMed ID: 32386492
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
